Merger Notification - Announcement according to § 10 Cartel Act
Sanofi; Cheplapharm SE
BWB/Z-7493
On 21.09.2026 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Sanofi (France) intends to acquire a non-controlling minority shareholding of more than 25% of the share capital and voting rights in Cheplapharm SE (Germany).
C - MANUFACTURING C 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations, C 21.1 - Manufacture of basic pharmaceutical products, C 21.10 - Manufacture of basic pharmaceutical products, G - WHOLESALE AND RETAIL TRADE, G 46 - Wholesale trade, G 46.4 - Wholesale of household goods, G 46.46 - Wholesale of pharmaceutical and medical goods
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 19.10.2026.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.